Profil
Tim Kievits is the founder of PamGene BV and VitrOmics Healthcare Holding BV, both founded in 1999.
At PamGene BV, he holds the title of Chief Executive Officer since 2010 and is currently the Chief Executive Officer at PamGene International BV since 1999.
He was also the Director-Healthcare Innovation at VitrOmics Healthcare Holding BV.
Mr. Kievits's former positions include Technology Director at Organon Teknika BV and Principal at the University of Leiden.
Postes actifs de Tim Kievits
| Sociétés | Poste | Début |
|---|---|---|
PamGene BV
 PamGene BV Pharmaceuticals: MajorHealth Technology PamGene BV provides biopharmaceutical products and clinical settings. It also provides PamChip biomarkers, such as tyrosine kinases, serine/threonine kinases, nuclear receptors, and reagent kits. The firm provides BioNavigator, a software tool for interpretation of PamChip measurements, as well as for performing data analysis for various PamChip experiments; and Evolve that enables data capture and analysis, as well as for the export of data into third party software formats. The company was founded by Tim Kievits in December 1999 and is headquartered in 's-Hertogenbosch, the Netherlands. | Directeur Général | 01/01/1999 |
PamGene International BV
 PamGene International BV Pharmaceuticals: MajorHealth Technology PamGene is a biomarker company, focused on opening up new opportunities for the development of Personalized Medicine (pre-clinical, translational and clinical). Most of PamGene's projects are in oncology and many of these involve medicines that inhibit or modulate cellular kinases and kinase pathways. The firm collaborators apply its technologies for biomarker research in several other diseases and fields of expertise such as the Central Nervous System, the Cardiovascular area, Immunology and Obesity. PamGene's technology offers a faster and lower risk route for discovery and development of clinically useful biomarkers and uses cell lines and retrospective patient sample collection testing. | Directeur Général | 01/01/1999 |
Anciens postes connus de Tim Kievits
| Sociétés | Poste | Fin |
|---|---|---|
| University of Leiden | Corporate Officer/Principal | - |
VitrOmics Healthcare Holding BV
 VitrOmics Healthcare Holding BV Pharmaceuticals: MajorHealth Technology VitrOmics Healthcare Holding BV is a holding company, which engages in the development of new diagnostic products based on the PamChip technology platform. Its platform is used for academic and bio-pharmaceutical research applications. The company was founded by Tim Kievits and is headquartered in 's-Hertogenbosch, the Netherlands. | Fondateur | - |
Organon Teknika BV
 Organon Teknika BV Medical SpecialtiesHealth Technology Organon Teknika BV manufactures HIV diagnostic products, including NucliSens HIV-1 viral load and nucliSens HIV-1 RNA detection assays. The company is headquartered in Boxtel, the Netherlands. | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
PamGene BV
PamGene BV Pharmaceuticals: MajorHealth Technology PamGene BV provides biopharmaceutical products and clinical settings. It also provides PamChip biomarkers, such as tyrosine kinases, serine/threonine kinases, nuclear receptors, and reagent kits. The firm provides BioNavigator, a software tool for interpretation of PamChip measurements, as well as for performing data analysis for various PamChip experiments; and Evolve that enables data capture and analysis, as well as for the export of data into third party software formats. The company was founded by Tim Kievits in December 1999 and is headquartered in 's-Hertogenbosch, the Netherlands. | Health Technology |
PamGene International BV
PamGene International BV Pharmaceuticals: MajorHealth Technology PamGene is a biomarker company, focused on opening up new opportunities for the development of Personalized Medicine (pre-clinical, translational and clinical). Most of PamGene's projects are in oncology and many of these involve medicines that inhibit or modulate cellular kinases and kinase pathways. The firm collaborators apply its technologies for biomarker research in several other diseases and fields of expertise such as the Central Nervous System, the Cardiovascular area, Immunology and Obesity. PamGene's technology offers a faster and lower risk route for discovery and development of clinically useful biomarkers and uses cell lines and retrospective patient sample collection testing. | Health Technology |
Organon Teknika BV
Organon Teknika BV Medical SpecialtiesHealth Technology Organon Teknika BV manufactures HIV diagnostic products, including NucliSens HIV-1 viral load and nucliSens HIV-1 RNA detection assays. The company is headquartered in Boxtel, the Netherlands. | Health Technology |
VitrOmics Healthcare Holding BV
VitrOmics Healthcare Holding BV Pharmaceuticals: MajorHealth Technology VitrOmics Healthcare Holding BV is a holding company, which engages in the development of new diagnostic products based on the PamChip technology platform. Its platform is used for academic and bio-pharmaceutical research applications. The company was founded by Tim Kievits and is headquartered in 's-Hertogenbosch, the Netherlands. | Health Technology |